121 related articles for article (PubMed ID: 8105795)
1. Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma.
Enomoto T; Fujita M; Inoue M; Nakazawa-Miyamoto A; Tanizawa O; Nomura T
Mol Carcinog; 1993; 8(3):132-7. PubMed ID: 8105795
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
3. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
5. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
[TBL] [Abstract][Full Text] [Related]
8. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the retinoblastoma gene in human endometrial carcinoma.
Yaginuma Y; Katayama H; Kawai K; Duenas JC; Ishikawa M
Obstet Gynecol; 1996 May; 87(5 Pt 1):755-9. PubMed ID: 8677081
[TBL] [Abstract][Full Text] [Related]
10. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
11. Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci.
Miyamoto H; Kubota Y; Shuin T; Shiozaki H
Cancer Genet Cytogenet; 1996 Jun; 88(2):181-3. PubMed ID: 8640732
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
[TBL] [Abstract][Full Text] [Related]
13. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas.
Hall KL; Teneriello MG; Taylor RR; Lemon S; Ebina M; Linnoila RI; Norris JH; Park RC; Birrer MJ
Gynecol Oncol; 1997 May; 65(2):330-5. PubMed ID: 9159347
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
Jiko K; Tsuda H; Sato S; Hirohashi S
Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.
Greenwald BD; Harpaz N; Yin J; Huang Y; Tong Y; Brown VL; McDaniel T; Newkirk C; Resau JH; Meltzer SJ
Cancer Res; 1992 Feb; 52(3):741-5. PubMed ID: 1346256
[TBL] [Abstract][Full Text] [Related]
17. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in thyroid tumor progression: association with p53 gene mutations.
Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi Y; Dohi K; Nakamura N; Akiyama M
Jpn J Cancer Res; 1993 May; 84(5):526-31. PubMed ID: 8100564
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
20. p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
Choi SW; Park WS; Yang JM; Kang CS; Sun HS; Kim BS; Seo EJ; Lee MJ; Park CS
J Korean Med Sci; 1994 Aug; 9(4):299-303. PubMed ID: 7848577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
